All You Need to Know About OptimizeRx ( OPRX ) Rating Upgrade to Strong Buy
OptimizeRx (OPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stock to Buy for August 21st
OPRX, BZ and ANET made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 21, 2025.
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
WALTHAM, Mass., Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) ( Nasdaq: OPRX ) , a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced organizational updates ...
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Click Holdings ( NASDAQ:CLIK ) , BioVie ( NASDAQ:BIVI )
Shares of Expedia Group, Inc. EXPE rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates. Expedia reported second-quarter revenue of $3.79 billion, up 6% year-over-year.
OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push - OptimizeRx ( NASDAQ:OPRX )
Following the release of its second-quarter financial results, OptimizerRx Corp OPRX stock witnessed a 22.66% surge during after-hours trading on Thursday. Check out the current price of OPRX stock here. What Happened: The Michigan-based digital health company's stock soared to $15.75 per share ...
OptimizeRx Corp. ( OPRX ) Surpasses Q2 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +700.00% and +30.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Shopify Q2 Earnings Beat Estimates, Revenues Jump Y/Y, Shares Rise
SHOP surges 22% after Q2 beats, fueled by strong GMV growth, rising merchant revenues, and upbeat Q3 guidance.
MKSI Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Rise
MKS Instruments' second-quarter 2025 results reflect strong growth in the Semiconductor, and Electronics and Packaging markets.
Fastly Posts Narrower Loss in Q2 Earnings, Revenues Rise Y/Y
FSLY pops 10.6% pre-market as Q2 loss narrows and revenues jump 12.3%, topping estimates on both lines.
Best Growth Stocks to Buy for August 7th
WDC, OPRX and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August ...
Smith Micro Software, Inc. ( SMSI ) Reports Q2 Loss, Misses Revenue Estimates
Smith Micro Software (SMSI) delivered earnings and revenue surprises of -7.69% and -5.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMD Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Fall
Advanced Micro Devices' second-quarter 2025 performance benefits from strong data center and gaming growth, but shares slip on export-related setbacks.
Best Growth Stocks to Buy for August 5th
PRIM, OPRX and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August ...
Best Growth Stocks to Buy for August 1st
OPRX, JBL and ADRNY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 1, 2025.
Bull Of The Day: OptimizeRX ( OPRX )
This stock is reporting earnings next week and posting positive operating margins is going to be key.
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
OPRX's subscription shift, DAAP platform, and HCP-DTC reach suggest a moat is forming-but is it built to last?
Blackbaud ( BLKB ) Q2 Earnings and Revenues Surpass Estimates
Blackbaud (BLKB) delivered earnings and revenue surprises of +15.24% and +1.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Markets: AngloGold Ashanti, Caterpillar & Hershey in Focus
AU, CAT and HSY are standing out as Zacks' high-conviction picks, with each posting double-digit gains in recent weeks.
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
OptimizeRx posts 11% Q1 growth and rising EBITDA, but long-term momentum hinges on scaling subscriptions and margin mix gains.
Best Growth Stocks to Buy for July 22nd
OPRX, ADRNY and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 22, 2025.
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition?
OptimizeRx bets on EHR-linked messaging and geo-targeting to stand out, but scaling in a crowded digital health field remains key.
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
WALTHAM, Mass., July 17, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) ( Nasdaq: OPRX ) , a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, will hold a conference call on ...
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - OptimizeRx ( NASDAQ:OPRX )
WALTHAM, Mass., July 17, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) OPRX, a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, will hold a conference call on Thursday, August 7, ...
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?
OPRX is growing faster with rising subscription revenues and strong pharma demand, while GDRX lags due to slower consumer growth.
Synopsys ( SNPS ) Moves 3.6% Higher: Will This Strength Last?
Synopsys (SNPS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.
Best Growth Stocks to Buy for July 9th
OPRX, EWCZ and QFIN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 9, 2025.
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
OPRX raised guidance after record Q1 EBITDA, but pharma budget shifts and margin mix pose new challenges ahead.
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?
OPRX surged 69.3% in three months as rising contracted revenue and subscription gains boost confidence and guidance.
Best Growth Stocks to Buy for June 25th
OPRX, GLDD and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June ...
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
WALTHAM, Mass., June 24, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) ( Nasdaq: OPRX ) , a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced the appointment of ...
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors - OptimizeRx ( NASDAQ:OPRX )
WALTHAM, Mass., June 24, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) OPRX, a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced the appointment of Steve Silvestro, ...
Here's Why OptimizeRx Corp. ( OPRX ) is a Great Momentum Stock to Buy
Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
New Strong Buy Stocks for June 4th
BCRX, OPRX, BWB, PLMR and RACE have been added to the Zacks Rank #1 (Strong Buy) List on June 4, 2025.
DSGX's Solution Used by ArrowXL to Boost Last Mile Delivery
Descartes announces that ArrowXL is leveraging its cloud-based route planning and execution solution to streamline last mile delivery operations.
Earnings Estimates Rising for OptimizeRx ( OPRX ) : Will It Gain?
OptimizeRx (OPRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
OptimizeRx to Participate in Upcoming Investor Conferences
WALTHAM, Mass., May 16, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) ( Nasdaq: OPRX ) , a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced that management will ...
OptimizeRx to Participate in Upcoming Investor Conferences - OptimizeRx ( NASDAQ:OPRX )
WALTHAM, Mass., May 16, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) OPRX, a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced that management will participate in ...
US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert - Acadia Healthcare Co ( NASDAQ:ACHC )
U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket. Tech, consumer discretionary, and communication services led Monday's rally as stocks surged on the tariff truce with China.
OptimizeRx Corp. ( OPRX ) Beats Q1 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of 172.73% and 15.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Microsoft ( MSFT ) Q3 Earnings and Revenues Beat Estimates
Microsoft (MSFT) delivered earnings and revenue surprises of 8.13% and 2.46%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cadence Design Systems ( CDNS ) Beats Q1 Earnings and Revenue Estimates
Cadence (CDNS) delivered earnings and revenue surprises of 5.37% and 0.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - OptimizeRx ( NASDAQ:OPRX )
WALTHAM, Mass., April 23, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) OPRX, a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional ( HCPs ) and patients, will hold a conference call on Monday, May 12, 2025, ...
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - OptimizeRx ( NASDAQ:OPRX )
WALTHAM, Mass., April 18, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) OPRX, a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced that, as part of OptimizeRx's ...
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - OptimizeRx ( NASDAQ:OPRX )
OptimizeRx reports a 29% annual revenue increase to $92.1 million, with Q4 revenue up 14% year-over-year to $32.3 million. The company forecasts at least $100 million in revenue and an adjusted EBITDA of at least $12 million for 2025. Find out which stock just claimed the top spot in the new ...
OptimizeRx Corp. ( OPRX ) Q4 Earnings and Revenues Beat Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of 20% and 9.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
No Stockholder Action Required at this Time No Stockholder Action Required at this Time ...
Oracle ( ORCL ) Q3 Earnings and Revenues Miss Estimates
Oracle (ORCL) delivered earnings and revenue surprises of -0.68% and 1.59%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer - OptimizeRx ( NASDAQ:OPRX )
WALTHAM, Mass., March 10, 2025 ( GLOBE NEWSWIRE ) -- OptimizeRx Corp. ( the "Company" ) OPRX, a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals ( HCPs ) and patients, today announced it has appointed Steve Silvestro as ...
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team ...
